Some Haematological Profile of HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) in Usmanu Danfodiyo University Teaching Hospital Sokoto, North Western Nigeria

American Journal of Science and Technology

MohammedHaruna Yeldu¹  YakubuAbdulrahaman²  AminuAmina²  IsaacIsah Zama² 

[1] Chemical Pathology Department, Faculty of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria.;Haematology Department, Faculty of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria.

关键词: PCV;    TLC;    PLC;    HIV and HAART Treatment;   

学科分类：工程和技术（综合）

来源: AASCIT

【 摘 要 】

Treatment of HIV/AIDS patients, with HAART is the common practice in most of our health institutions, and the effect of this drug on anemia, leucopenia and thrombocytopenia in this group of patients has not been fully studied in our locality. With the wide spread side effect associated with HAART drugs, there is need to evaluate the role of HAART as it affect hematological indices. Using haematocrit centrifuge method, Burker and haemocytometer method, Packed cell volume (PCV), Total leucocyte count (TLC) and platelet count (PLC) were evaluated and the values obtained in HIV/AIDS patients not on HAART and HIV/AIDS patients on HAART were compared with apparently healthy controls. The result indicated that the mean PCV values of 38.300±4.547%, 32.467±7.133% and 34.263±7.668%, TLC, 6.360±1.567×109/L, 3.423±1.657×109/L and 3.501±1.132 ×109/L, PLC, 253.33±65.090 ×109/L, 207.37±74.65×109/L and 216.95±73.92×109/L in controls, HIV/AIDS patients not on HAART and in HIV patients on HAART treatment respectively. There were statistically significant difference (P< 0.05), between HIV patients on HAART and the controls. However there were no statistically significant difference (P>0.05) between the HIV positive on HAART and HIV positive not on HAART. However, the report from the laboratory analysis of the blood sample showed that HAART therapy increased PCV, TLC, and PLC cell count of the subjects. Therefore, we concluded that, HAART treatment from these studies has the capability of reducing the incidence of anemia, lymphopoenia and thrombocytopenia which are associated with HIV/AIDS disease progression and death in infected patients. Total lymphocyte count, Packed Cell Volume and platelet count could also serve as useful predictive tools in the management and monitoring of HIV/AIDS infected patients in resource limited settings.

【 授权许可】

Unknown